Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Ambrx Biopharma, Inc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is -1.33% vs -45.26% in Dec 2021",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is -14.20% vs -283.71% in Dec 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.40",
          "val2": "7.50",
          "chgp": "-1.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-62.20",
          "val2": "-60.70",
          "chgp": "-2.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-9.70",
          "val2": "-3.90",
          "chgp": "-148.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-78.00",
          "val2": "-68.30",
          "chgp": "-14.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-9,016.60%",
          "val2": "-8,641.70%",
          "chgp": "-37.49%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'22

Dec'22

Dec'21

Change(%)

Net Sales

7.40

7.50

-1.33%

Operating Profit (PBDIT) excl Other Income

-62.20

-60.70

-2.47%

Interest

1.00

0.00

Exceptional Items

-9.70

-3.90

-148.72%

Consolidate Net Profit

-78.00

-68.30

-14.20%

Operating Profit Margin (Excl OI)

-9,016.60%

-8,641.70%

-37.49%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2022 is -1.33% vs -45.26% in Dec 2021

Consolidated Net Profit

YoY Growth in year ended Dec 2022 is -14.20% vs -283.71% in Dec 2021

All Annual Results